Randomized controlled trial of taurolidine citrate versus heparin as catheter lock solution in paediatric patients with haematological malignancies

Journal of Hospital Infection

Volumn 80, Issue 4, 2012, Pages 304-309

  Dumichen M J ^a   Seeger, K ^a   Lode, H N ^a,b   Kuhl J S ^a   Ebell, W ^a   Degenhardt, P ^a   Singer, M ^a   Geffers, C ^a   Querfeld, U ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY MEDICINE GREIFSWALD   (Germany)

Author keywords

Bone marrow transplantation; Catheter related infections; Chemotherapy; Children; Heparin; Taurolidine citrate

Indexed keywords

HEPARIN; TAUROLIDINE;

ADOLESCENT; ADULT; ARTICLE; BACILLUS PUMILUS; BACTERIAL GROWTH; CATHETER OCCLUSION; CENTRAL VENOUS CATHETER; CHILD; CONTROLLED STUDY; FEMALE; HEMATOLOGIC MALIGNANCY; HUMAN; HUMAN TISSUE; INFANT; INFECTION COMPLICATION; MAJOR CLINICAL STUDY; MALE; MICROBIAL COLONIZATION; NAUSEA AND VOMITING; NECK DISCOMFORT; NECK PAIN; ORAL DYSESTHESIA; PRESCHOOL CHILD; PYREXIA IDIOPATHICA; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; STAPHYLOCOCCUS EPIDERMIDIS; TASTE DISORDER; THORAX PAIN;

ADOLESCENT; ANTI-INFECTIVE AGENTS, LOCAL; ANTICOAGULANTS; BACTERIA; CATHETER-RELATED INFECTIONS; CATHETERIZATION; CATHETERS, INDWELLING; CHILD; CHILD, PRESCHOOL; FEMALE; FEVER OF UNKNOWN ORIGIN; HEMATOLOGIC NEOPLASMS; HEPARIN; HUMANS; INCIDENCE; INFANT; MALE; SURVIVAL ANALYSIS; TAURINE; THIADIAZINES;

EID: 84858281694     PISSN: 01956701     EISSN: 15322939     Source Type: Journal    
DOI: 10.1016/j.jhin.2012.01.003     Document Type: Article

References (12)

1. Torres-Viera C., Thauvin-Eliopoulos C., Souli M., et al. Activities of taurolidine in vitro and in experimental enterococcal endocarditis. Antimicrob Agents Chemother 2000, 44:1720-1724.
2. Shah C.B., Mittelman M.W., Costerton J.W., et al. Antimicrobial activity of a novel catheter lock solution. Antimicrob Agents Chemother 2002, 46:1674-1679.
3. Traub W.H., Leonhard B., Bauer D. Taurolidine: in vitro activity against multiple-antibiotic-resistant, nosocomially significant clinical isolates of Staphylococcus aureus, Enterococcus faecium, and diverse Enterobacteriaceae. Chemotherapy 1993, 39:322-330.
4. Gorman S.P., McCafferty D.F., Woolfson A.D., Jones D.S. A comparative study of the microbial antiadherence capacities of three antimicrobial agents. J Clin Pharm Ther 1987, 12:393-399.
5. Raad I.I., Fang X., Keutgen X.M., Jiang Y., Sherertz R., Hachem R. The role of chelators in preventing biofilm formation and catheter-related bloodstream infections. Curr Opin Infect Dis 2008, 21:385-392.
6. Simon A., Ammann R.A., Wiszniewsky G., Bode U., Fleischhack G., Besuden M.M. Taurolidine-citrate lock solution (TauroLock) significantly reduces CVAD-associated grampositive infections in paediatric cancer patients. BMC Infect Dis 2008, 8:102.
7. Henrickson K.J., Axtell R.A., Hoover S.M., et al. Prevention of central venous catheter-related infections and thrombotic events in immunocompromised children by the use of vancomycin/ciprofloxacin/heparin flush solution: a randomized, multicenter, double-blind trial. J Clin Oncol 2000, 18:1269-1278.
8. Sherertz R.J., Raad I.I., Belani A., et al. Three-year experience with sonicated vascular catheter cultures in a clinical microbiology laboratory. J Clin Microbiol 1990, 28:76-82.
9. Maki D.G., Kluger D.M., Crnich C.J. The risk of bloodstream infection in adults with different intravascular devices: a systematic review of 200 published prospective studies. Mayo Clin Proc 2006, 81:1159-1171.
10. Raad I., Costerton W., Sabharwal U., Sacilowski M., Anaissie E., Bodey G.P. Ultrastructural analysis of indwelling vascular catheters: a quantitative relationship between luminal colonization and duration of placement. J Infect Dis 1993, 168:400-407.
11. Walz J.M., Memtsoudis S.G., Heard S.O. Analytic reviews: prevention of central venous catheter bloodstream infections. J Intensive Care Med 2010, 25:131-138.
12. Mandolfo S., Borlandelli S., Elli A. Catheter lock solutions: it's time for a change. J Vasc Access 2006, 7:99-102.